PGR and amenorrhea: Ulipristal is a selective progesterone receptor modulator (SPRM) have been successful to reach amenorrhea in 70-80% of women, with a faster median onset of 4 days to reach it and less adverse effects when compared to GnRH analogues [25]; however, this drug was not tested in women under 18 years.